XSEED CON is a 2-day event offering cross-pollination between researchers from distinct disciplines (nanotechnology, bioinformatics, genetics, biophysics, cell biology), to go beyond the current boundaries in biomedical research, and to plant intellectual seeds about future technologies in the minds of all participants.
Scientists from both academia and industry will bridge the gap between the two worlds.
The event will go from May 3-4 2018 in Heidelberg, Germany.
Elena Cattaneo – University Milan, Italy
Michael Hayden – Teva, Israel
John P. Overington – Medicines Discovery Catapult, UK
William Shih – Harvard Medical School, Boston, USA
Christoph Bock – CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Philippe Bousso – Pasteur Institute, Paris, France
Adrian Carter – Boehringer Ingelheim, Ingelheim am Rhein, Germany
Robert Lucas – University of Manchester, UK
Serena Nik-Zainal – Sanger Institute, Hinxton, UK
Rienk Offringa – German Cancer Research Center, Heidelberg, Germany
Lucas Pelkmans – University of Zurich, Switzerland